We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IMKTA:NASDAQIngles Markets, Incorporated Analysis

Data as of 2026-04-10 - not real-time

$94.79

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Ingles Markets (IMKTA) is trading at $94.79, just below its 52‑week high of $95.62 and comfortably above its 20‑day SMA of $89.01, indicating a strong bullish technical backdrop. The RSI of 72.9 signals overbought conditions, while a bullish MACD and a price comfortably above the 200‑day SMA support continued upside momentum. Recent material news confirms a fresh dividend declaration of $0.165 per share, reinforcing the company’s commitment to returning cash to shareholders. However, the DCF‑derived fair value of $55.56 is far below the current market price, suggesting the stock is significantly overvalued relative to intrinsic estimates. The balance sheet shows a high debt load ($647.8 M) with a debt‑to‑equity ratio of 76.6% and minimal cash reserves, raising concerns about financial flexibility. Despite modest revenue growth of 3.4% and thin profit margins, the dividend payout ratio sits at a prudent 13%, indicating the dividend is likely sustainable in the near term. Volatility is elevated at 22% over the past 30 days, but the beta of 0.26 points to low market‑related risk. Overall, the stock presents a mixed picture: strong short‑term technical momentum but long‑term valuation and leverage challenges.
Investors should weigh the defensive nature of the grocery sector against the overvaluation and debt concerns, using the dividend as a modest cushion while monitoring price action near the $95.62 resistance level.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at $95.62
  • RSI indicating overbought conditions
  • Bullish technical trend supports holding

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Defensive grocery sector provides stability
  • Sustainable dividend with low payout ratio
  • High debt levels limit upside potential

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • DCF fair value far below market price
  • Modest revenue growth and thin margins
  • Strong defensive positioning offsets valuation concerns

Key Metrics & Analysis

Financial Health

Revenue Growth3.40%
Profit Margin1.76%
P/E Ratio18.9
ROE5.94%
ROA3.53%
Debt/Equity76.57
P/B Ratio1.1
Op. Cash Flow$236.2M
Free Cash Flow$108.0M

Technical Analysis

TrendBullish
RSI72.9
Support$82.14
Resistance$95.62
MA 20$89.01
MA 50$86.46
MA 200$73.82
MACDBullish
VolumeStable
Fear & Greed Index87.66

Valuation

Fair Value$55.56
GradeOvervalued
TypeValue
Dividend Yield0.69%

Risk Assessment

Beta0.26
Volatility22.01%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.